GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NKGen Biotech Inc (NAS:NKGN) » Definitions » Interest Expense

NKGen Biotech (NKGen Biotech) Interest Expense : $-0.65 Mil (TTM As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is NKGen Biotech Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. NKGen Biotech's interest expense for the three months ended in Dec. 2023 was $ -0.44 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.65 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. NKGen Biotech's Operating Income for the three months ended in Dec. 2023 was $ -9.43 Mil. NKGen Biotech's Interest Expense for the three months ended in Dec. 2023 was $ -0.44 Mil. NKGen Biotech did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

NKGen Biotech Interest Expense Historical Data

The historical data trend for NKGen Biotech's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NKGen Biotech Interest Expense Chart

NKGen Biotech Annual Data
Trend Dec21 Dec22 Dec23
Interest Expense
-1.32 -2.31 -0.75

NKGen Biotech Quarterly Data
Dec21 Sep22 Dec22 Sep23 Dec23
Interest Expense - -0.64 -0.62 -0.21 -0.44

NKGen Biotech Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.65 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NKGen Biotech  (NAS:NKGN) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

NKGen Biotech's Interest Expense for the three months ended in Dec. 2023 was $-0.44 Mil. Its Operating Income for the three months ended in Dec. 2023 was $-9.43 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was $9.93 Mil.

NKGen Biotech's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

NKGen Biotech did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

NKGen Biotech (NKGen Biotech) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NKGen Biotech Inc (NAS:NKGN) » Definitions » Interest Expense
Comparable Companies
OCUP CASI SPRO XLO NGM GBIO ASMB CCCC OCEA FIXX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
19700 Fairchild Road, Suite No. 300, Irvine, CA, USA, 92612
Website
https://www.nkgenbiotech.com
NKGen Biotech Inc is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies utilizing our proprietary SNK (super-activated) platform.